Equity Profile

MLYS

Mineralys Therapeutics, Inc.

Health CareBiotechnology$2.4B

Aug12Wed

Pre-Earnings Brief

UpcomingQ2-2026After Close5:00 PM EDT

Company Snapshot

Mineralys Therapeutics, Inc. is a biotechnology company focused on developing innovative treatments for various health conditions....

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of the company's profitability and financial health, which investors closely monitor.

N/A

Revenue Growth

Revenue growth reflects the company's ability to expand its market presence and sales, which is vital for future investments.

N/A

Wall Street expectations, options signals, track record, and call prep available with Pro.

MLYS Q2-2026 Earnings Preview

Context

Company Snapshot

Mineralys Therapeutics, Inc. is a biotechnology company focused on developing innovative treatments for various health conditions. Operating in the healthcare sector, its work is crucial as it aims to address unmet medical needs and improve patient outcomes.

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

75%

Avg EPS Surprise

+6.74%

Avg Stock Reaction

+5.24%

Last Quarter Recap

In Q1-2026, Mineralys reported an EPS of -$0.47, which was better than the expected -$0.51, resulting in a positive surprise of 7.30%. Following the announcement, the stock rose by 2.87% the next day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Overall, expectations for this quarter are mixed, with investors looking for signs of improved financial performance and potential revenue growth.

Bull Case

The optimistic view hinges on the company continuing its trend of beating earnings expectations, which could lead to increased investor confidence and stock price appreciation.

Bear Case

Conversely, if the company fails to meet expectations or provides weak guidance, it could lead to a decline in stock price and investor sentiment.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will the EPS be this quarter, and how does it compare to previous quarters?

Given the company's recent history of beating EPS estimates, this figure will be crucial in determining investor sentiment.

What guidance will management provide regarding future revenue growth?

Investors will be closely watching for any signs of growth or challenges that could impact the company's future performance.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating the potential for Mineralys to exceed EPS expectations given its recent performance trends.

Supporting Evidence

The company has a 75% EPS beat rate over the last eight quarters, indicating a strong likelihood of positive surprises.

The options market is pricing in a significant move, suggesting that investors expect a notable reaction regardless of the outcome.

Key Risk

If the EPS comes in better than -$0.40, it could shift the narrative significantly towards a more positive outlook.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance is critical as it will either reinforce the company's positive trajectory or highlight potential weaknesses.

Bull Confirmed If

An EPS of -$0.40 or better would confirm the bull case, indicating continued improvement in profitability.

Bear Confirmed If

An EPS worse than -$0.60 would confirm the bear case, suggesting ongoing challenges.

Pre-Earnings Positioning

Options Market

Implied Move

±28.1%

Historical Avg

±6.1%

Pricing rich

The options market is pricing in a significant move, suggesting that investors expect volatility around the earnings announcement.

Options are pricing ±28.1% while MLYS has averaged ±6.1% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.8%

30d HV

60.3%

Calls (863K)P/C Ratio: 2.39Puts (188K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Mineralys beats expectations, history suggests a potential stock increase of around 5.22%, confirming the company's positive momentum.

In-Line / Cautious

If results are in line with expectations but management's commentary is cautious, the stock may experience minimal movement as investors reassess their outlook.

Miss

Should the company miss expectations, history suggests a potential decline of around 5.29%, which could lead to a reassessment of the company's growth prospects.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on ongoing clinical trials and their expected timelines.
2Management's commentary on market conditions and competitive landscape.
3Insights into cost management strategies and their impact on future profitability.
4Details on partnerships or collaborations that could enhance growth prospects.
5Any changes in regulatory environment affecting product development.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Aug10

BWBMO

Babcock & Wilcox Enterprises, Inc.

PreviewView

Aug10

ROIVBMO

Company Snapshot

Mineralys Therapeutics, Inc. is a biotechnology company focused on developing innovative treatments for various health conditions....

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of the company's profitability and financial health, which investors closely monitor.

N/A

Revenue Growth

Revenue growth reflects the company's ability to expand its market presence and sales, which is vital for future investments.

N/A

Wall Street expectations, options signals, track record, and call prep available with Pro.

MLYS Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

75%

Avg EPS Surprise

+6.74%

Avg Stock Reaction

+5.24%

Last Quarter Recap

Management Promises & Guidance

Expectations

Wall Street Expectations

Overall, expectations for this quarter are mixed, with investors looking for signs of improved financial performance and potential revenue growth.

Bull Case

The optimistic view hinges on the company continuing its trend of beating earnings expectations, which could lead to increased investor confidence and stock price appreciation.

Bear Case

Conversely, if the company fails to meet expectations or provides weak guidance, it could lead to a decline in stock price and investor sentiment.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will the EPS be this quarter, and how does it compare to previous quarters?

Given the company's recent history of beating EPS estimates, this figure will be crucial in determining investor sentiment.

What guidance will management provide regarding future revenue growth?

Investors will be closely watching for any signs of growth or challenges that could impact the company's future performance.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating the potential for Mineralys to exceed EPS expectations given its recent performance trends.

Supporting Evidence

The company has a 75% EPS beat rate over the last eight quarters, indicating a strong likelihood of positive surprises.

The options market is pricing in a significant move, suggesting that investors expect a notable reaction regardless of the outcome.

Key Risk

If the EPS comes in better than -$0.40, it could shift the narrative significantly towards a more positive outlook.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance is critical as it will either reinforce the company's positive trajectory or highlight potential weaknesses.

Bull Confirmed If

An EPS of -$0.40 or better would confirm the bull case, indicating continued improvement in profitability.

Bear Confirmed If

An EPS worse than -$0.60 would confirm the bear case, suggesting ongoing challenges.

Pre-Earnings Positioning

Options Market

Implied Move

±28.1%

Historical Avg

±6.1%

Pricing rich

The options market is pricing in a significant move, suggesting that investors expect volatility around the earnings announcement.

Options are pricing ±28.1% while MLYS has averaged ±6.1% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.8%

30d HV

60.3%

Calls (863K)P/C Ratio: 2.39Puts (188K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Mineralys beats expectations, history suggests a potential stock increase of around 5.22%, confirming the company's positive momentum.

In-Line / Cautious

If results are in line with expectations but management's commentary is cautious, the stock may experience minimal movement as investors reassess their outlook.

Miss

Should the company miss expectations, history suggests a potential decline of around 5.29%, which could lead to a reassessment of the company's growth prospects.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on ongoing clinical trials and their expected timelines.
2Management's commentary on market conditions and competitive landscape.
3Insights into cost management strategies and their impact on future profitability.
4Details on partnerships or collaborations that could enhance growth prospects.
5Any changes in regulatory environment affecting product development.